James W. Antoon

James W. Antoon

Auto-generated profile, based on publicly available information

James W. Antoon

Division of Hospital Medicine, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2021 in Journal of Hospital Medicine
Verified
Journal Article
Open access
PDF file
JAJames W Antoon
James W Antoon
CGCarlos G Grijalva
Carlos G Grijalva
CTCary Thurm
Cary Thurm
TRTroy Richardson
Troy Richardson
ASAlicen B Spaulding
Alicen B Spaulding
DWDerek J Williams
Derek J Williams
BACKGROUND: Little is known about the clinical factors associated with COVID‐19 disease severity in children and adolescents.METHODS: We conducted a retrospective cohort study across 45 US children's hospitals between April 2020 to September 2020 of pediatric patients discharged with a primary diagnosis of COVID‐19. We assessed factors associated with hospitalization and factors associated with clinical severity (eg, admission to inpatient floor, admission to intensive care unit [ICU], admission to ICU with mechanical ventilation, shock, death) among those hospitalized.RESULTS: Among 19,976 COVID‐19 encounters, 15,913 (79.7%) patients were discharged from the emergency department (ED) and 4063 (20.3%) were hospitalized. The clinical severity distribution among those hospitalized was moderate (3222, 79.3%), severe (431, 11.3%), and very severe (380, 9.4%). Factors associated with hospitalization vs discharge from the ED included private payor insurance (adjusted odds ratio [aOR],1.16; 95% CI, 1.1‐1.3), obesity/type 2 diabetes mellitus (type 2 DM) (aOR, 10.4; 95% CI, 8.9‐13.3), asthma (aOR, 1.4; 95% CI, 1.3‐1.6), cardiovascular disease, (aOR, 5.0; 95% CI, 4.3‐5.8), immunocompromised condition (aOR, 5.9; 95% CI, 5.0‐6.7), pulmonary disease (aOR, 5.3; 95% CI, 3.4‐8.2), and neurologic disease (aOR, 3.2; 95% CI, 2.7‐5.8). Among children and adolescents hospitalized with COVID‐19, greater disease severity was associated with Black or other non‐White race; age greater than 4 years; and obesity/type 2 DM, cardiovascular, neuromuscular, and pulmonary conditions.CONCLUSIONS: Among children and adolescents presenting to US children's hospital EDs with COVID‐19, 20% were hospitalized; of these, 21% received care in the ICU. Older children and adolescents had a lower risk for hospitalization but more severe illness when hospitalized. There were differences in disease severity by race and ethnicity and the presence of selected comorbidities. These factors should be taken into consideration when prioritizing mitigation and vaccination strategies.

20 October 2022 in Pediatrics
Verified
Journal Article
Open access
PDF file
JAJames W. Antoon
James W. Antoon
MHMatt Hall
Matt Hall
LHLeigh M. Howard
Leigh M. Howard
AHAlison Herndon
Alison Herndon
KFKatherine L. Freundlich
Katherine L. Freundlich
DWDerek J. Williams
Derek J. Williams
BACKGROUND: Little is known about the epidemiology and outcomes of neurologic complications associated with coronavirus disease 2019 (COVID-19) in children. METHODS: We performed a cross-sectional study of children 2 months to <18 years of age with COVID-19 discharged from 52 children’s hospitals from March 2020 to March 2022. Neurologic complications were defined as encephalopathy, encephalitis, aseptic meningitis, febrile seizure, nonfebrile seizure, brain abscess and bacterial meningitis, Reye’s syndrome, and cerebral infarction. We assessed length of stay (LOS), ICU admission, 30 day readmissions, deaths, and hospital costs. We used multivariable logistic regression to identify factors associated with neurologic complications. RESULTS: Of 15 137 children hospitalized with COVID-19, 1060 (7.0%) had a concurrent diagnosis of a neurologic complication. The most frequent neurologic complications were febrile seizures (3.9%), nonfebrile seizures (2.3%), and encephalopathy (2.2%). Hospital LOS, ICU admission, ICU LOS, 30 day readmissions, deaths, and hospital costs were higher in children with neurologic complications compared with those without complications. Factors associated with lower odds of neurologic complications included: younger age (adjusted odds ratio [aOR]: 0.97; 95% confidence interval [CI]: 0.96–0.98), occurrence during delta variant predominant time period (aOR: 0.71; 95% CI: 0.57–0.87), presence of a nonneurologic complex chronic condition (aOR: 0.80; 95% CI: 0.69–0.94). The presence of a neurologic complex chronic condition was associated with higher odds of neurologic complication (aOR 4.14, 95% CI 3.48–4.92). CONCLUSIONS: Neurologic complications are common in children hospitalized with COVID-19 and are associated with worse hospital outcomes. Our findings emphasize the importance of COVID-19 immunization in children, especially in high-risk populations, such as those with neurologic comorbidity.

1 December 2021 in The Journal of Pediatrics
Verified
Journal Article
Closed access
JAJames W. Antoon
James W. Antoon
MHMatt Hall
Matt Hall
AHAlison Herndon
Alison Herndon
DJDavid P. Johnson
David P. Johnson
CBCharlotte M. Brown
Charlotte M. Brown
DWDerek J. Williams
Derek J. Williams

9 January 2018 in Pediatric Dermatology
Verified
Journal Article
Closed access
PDF file
JAJames W. Antoon
James W. Antoon
JGJennifer L. Goldman
Jennifer L. Goldman
BLBrian Lee
Brian Lee
ASAlan Schwartz
Alan Schwartz

1 May 2021 in Journal of Hospital Medicine
Verified
Journal Article
Closed access
PDF file
JAJames W Antoon
James W Antoon
DWDerek J Williams
Derek J Williams
CTCary Thurm
Cary Thurm
MBMichael Bendel‐Stenzel
Michael Bendel‐Stenzel
ASAlicen B Spaulding
Alicen B Spaulding
CGCarlos G Grijalva
Carlos G Grijalva
The impact of COVID‐19 public health interventions on pediatric illnesses nationwide is unknown. We performed a multicenter, cross‐sectional study of encounters at 44 children's hospitals in the United States to assess changes in healthcare utilization during the pandemic. The COVID‐19 pandemic was associated with substantial reductions in encounters for respiratory diseases; these large reductions were consistent across illness subgroups. Although encounters for nonrespiratory diseases decreased as well, reductions were more modest and varied by age. Encounters for respiratory diseases among adolescents declined to a lesser degree and returned to previous levels faster compared with those of younger children. Further study is needed to determine the contributions of decreased illness and changes in care‐seeking behavior to this observed reduction.

1 March 2018 in Hospital Pediatrics
Verified
Journal Article
Closed access
PDF file
JAJames W. Antoon
James W. Antoon
DPDavid C. Peritz
David C. Peritz
MPMichael R. Parsons
Michael R. Parsons
ASAsheley C. Skinner
Asheley C. Skinner
JLJacob A. Lohr
Jacob A. Lohr
BACKGROUND: Fever of unknown origin (FUO) is a well-known pediatric presentation. The primary studies determining the causes of prolonged fever in children were performed 4 decades ago, before major advances in laboratory and diagnostic testing. Given that the distribution of diagnosed causes of adult FUO has changed in recent decades, we hypothesized that the etiology of FUO in children has concordantly changed and also may be impacted by a definition that includes a shorter required duration of fever. METHODS: A single-center, retrospective review of patients 6 months to 18 years of age admitted to the North Carolina Children’s Hospital from January 1, 2002, to December 21, 2012, with an International Classification of Diseases, Ninth Revision diagnosis of fever, a documented fever duration >7 days before admission, and a previous physician evaluation of each patient’s illness. RESULTS: A total of 1164 patients were identified, and of these, 102 met our inclusion criteria for FUO. Etiologic categories included “infectious” (42 out of 102 patients), “autoimmune” (28 out of 102 patients), “oncologic” (18 out of 102 patients), and “other” or “unknown” (14 out of 102 patients). Several clinical factors were statistically and significantly different between etiologic categories, including fever length, laboratory values, imaging performed, length of stay, and hospital costs. CONCLUSIONS: Unlike adult studies, the categorical distribution of diagnoses for pediatric FUO has marginally shifted compared to previously reported pediatric studies. Patients hospitalized with FUO undergo prolonged hospital stays and have high hospital costs. Additional study is needed to improve the recognition, treatment, and expense of diagnosis of prolonged fever in children.